ANTIDEPRESSANT WITHDRAWAL & ALCOHOL: Mother Murders her 3 Year Old Daughter: IL

Paragraphs 15 through 19 read: “Throughout the interview Starr said she was in school because Bianca was the only ‘remotely good’ thing in her life.”

“She became hysterical when the detectives told her Bianca died.”

“ ‘I want her back,’ she cried.”

“The tape shows that Starr calmed down within minutes. Eventually she said, ‘Safe to say to say I killed her. Safe to say I’m going to go to jail. Safe to say I’m never going to be sane again’.”

“Starr also told investigators she had skipped a dose of an anti-depressant.”

http://www.wsiltv.com/p/news_details.php?newsID=9900&type=top

Prosecution Rests in Starr Case

MARION

After an emotional week in court, the Herrin woman on trial for killing her three-year-old daughter has decided not to testify, according to court documents.

Prosecutors began presenting their case against Karrae Starr, 20, by playing the tape of the 911 call she made in late September 2008.

They wrapped it up Friday morning by showing the jury a recording of her interview with investigators, which was conducted hours later.

In the video Starr wore a t-shirt with blood stains on it. She acknowledged the blood belonged to her daughter, Bianca.

During the interview, Starr told investigators Jill Blus of the Williamson County Sheriff’s Department and Bruce Graul of the Herrin Police Department she got angry when Bianca went to the playground with her boyfriend without telling her.

In the recording, Starr tells the investigators Bianca threw a fit when she dragged her home.
Once in Bianca’s bedroom, “I held my hand over her mouth” to make her stop screaming, Starr said.

“I was extremely [expletive] pissed off and drunk,” she continued. She told detectives she had five shots of vodka that night.

Starr said Bianca eventually calmed down, so she removed her hand, and asked Bianca if she was okay. Bianca said yes.

According to Starr, as she was leaving the room she heard Bianca get out of bed, so she turned around. When she did, she saw blood and foam coming from Bianca’s nose.

Thursday a forensic pathologist testified that the blood and foam, combined with swollen organs which were discovered during an autopsy, indicate Bianca was smothered.

“All indications are she didn’t stand up out of bed herself,” Blus told Starr.

Starr, who was a nursing student at the time, did CPR on her daughter. Eventually, she told investigators, “I picked her up and held her and told her to come back….I was giving up because she wasn’t responding.”

Starr said her boyfriend was in the other room on the computer as she gave Bianca CPR.

Throughout the interview Starr said she was in school because Bianca was the only “remotely good” thing in her life.

She became hysterical when the detectives told her Bianca died.

“I want her back,” she cried.

The tape shows that Starr calmed down within minutes. Eventually she said, “Safe to say to say I killed her. Safe to say I’m going to go to jail. Safe to say I’m never going to be sane again.”

Starr also told investigators she had skipped a dose of an anti-depressant.

As the recording played for the jury, Starr became visibly upset several times.

The trial continues Monday. It’s expected to wrap up by Tuesday.

U.S. Attorney Danny Kay and State’s Attorney Chuck Garnati are prosecuting the case. Public Defender Larry Broeking represents Starr.

By Dana Jay
djay@wsiltv.com

2,114 total views, no views today

ANTIDEPRESSANT WITHDRAWAL: NC man gets 27 years in mother’s beating death

YET ANOTHER INDICATION OF HOW HORRIFIC
ANTIDEPRESSANT WITHDRAWAL CAN BE. REACHING FOR ILLEGAL DRUGS OR ALCOHOL IN ORDER
TO LESSEN THE WITHDRAWAL EFFECTS WHEN YOU CANNOT GET YOUR ANTIDEPRESSANT IS A
COMMON REPORT.

His attorney says Heath had been drinking and smoking
crack the night of the killing. She also says her client had been waiting for an
appointment at a Veteran’s Affair clinic for a refill of his antidepressant
medication.

NC man gets 27 years in mother’s beating death

The Associated Press
Posted: Friday, Apr. 30, 2010

CHARLOTTE, N.C. A North Carolina man has been sentenced to nearly three
decades in prison in the beating death of his 83-year-old mother.

The Charlotte Observer reported that 56-year-old Jerry Heath was sentenced to
27 years in prison after pleading guilty Thursday to second-degree murder.

Authorities say Heath killed his mother over $35. Prosecutors say Jerry Heath
hit Annie Heath with a lamp in November after she refused to give him more
money.

The Charlotte man wept as his relatives told a judge they weren’t mad at
Heath.

His attorney says Heath had been drinking and smoking crack the night of the
killing. She also says her client had been waiting for an appointment at a
Veteran’s Affair clinic for a refill of his antidepressant medication.

Information from: The Charlotte Observer,
http://www.charlotteobserver.com

Read more: http://www.charlotteobserver.com/2010/04/30/1407185/ncmangets27yearsin-mothers.html#ixzz0mbP8tmbC

Reply
Forward
Reply to all
|

Atracyphd1@aol.com

to post

show details Apr 30 (6 days ago)
NOTE FROM Ann Blake-Tracy (www.drugawareness.org):
Welcome to abrupt antidepressant withdrawal!!!! Few things are more
dangerous! I have warned of this for 18 years now and in 2005 the FDA warned
that ANY abrupt change in dose of an antidepressant can produce suicide,
hostility and/or psychosis as a result. How tragic that the Heath family has
learned how true that is by first hand experience. To safely withdraw patients
MUST go extremely slowly down off these drugs.
And the fact remains that if Jerry Heath had substance abuse problems
before his use of an antidepressant he should NEVER have been prescribed one and
if he had no substance abuse problems before the prescription, those cravings
were induced by the use of the antidepressant. I AM SO SICK OF SEEING PEOPLE
WITH THESE PROBLEMS BEING GIVEN THESE DEADLY DRUGS WE CALL “ANTIDEPRESSANTS” AND
THE VA ARE AMONG THE VERY WORST AT HANDING THEM OUT LIKE CANDY!

NC man gets 27 years in mother’s beating death

The Associated Press
Posted: Friday, Apr. 30, 2010

CHARLOTTE, N.C. A North Carolina man has been sentenced to nearly three
decades in prison in the beating death of his 83-year-old mother.

The Charlotte Observer reported that 56-year-old Jerry Heath was sentenced to
27 years in prison after pleading guilty Thursday to second-degree murder.

Authorities say Heath killed his mother over $35. Prosecutors say Jerry Heath
hit Annie Heath with a lamp in November after she refused to give him more
money.

The Charlotte man wept as his relatives told a judge they weren’t mad at
Heath.

His attorney says Heath had been drinking and smoking crack the night of the
killing. She also says her client had been waiting for an appointment at a
Veteran’s Affair clinic for a refill of his antidepressant medication.

Information from: The Charlotte Observer,
http://www.charlotteobserver.com

Read more: http://www.charlotteobserver.com/2010/04/30/1407185/ncmangets27yearsin-mothers.html#ixzz0mbmg96tK

1,925 total views, no views today

Pfizer Dodges Fraud Prosecution AGAIN By Paying Over $1 Billion Fine

Pfizer Dodges Fraud Prosecution AGAIN By Paying HUGE Government

Fine

If it were you or I or your neighbor down the street you can
bet that NO presecutor on the planet would “look the other way” to avoid
prosecution. But, when it involves the lergest drug company on the planet they
seem to be able to do just that and do it VERY WELL!!!
So, before going into the amazing facts in this most recent
case let me give you a reminder of the last big case involving a large fine for
off label marketing with Pfizer‘s Neurontin. After learning that Pfizer sales
reps had been drastically increasing profits by pushing Neurontin for off label
uses for several years felony charges were filed against the company for
doing so. (Keep in mind that this drug now carries warnings of increases in
suicide.) In 2004 they plead guilty to two felonies and agreed to pay $430
Million in fines as well. See the first article below as a quick
overview.
Now they have a whole new twist when it comes to approaching
similar charges with the off label prescribing of Bextra (Pfizer‘s version of
Vioxx) which was pulled from the market just the following year after pleading
guilty to the two felonies in the Neurontin case and paying the largest fine
ever for such a practice. Pfizer acquired a smaller drug company
called Pharmacia and they wanted to market Bextra for surgical pain.
When the FDA put their foot down and clearly said, “NO because of safety
issues,” Pfizer and Pharmacia went right ahead with their marketing campaign. So
when caught red handed in doing this, the prosecutor decides that Pharmacia can
plead guilty so that Pfizer is off the hook because it would have put them out
of business!!!!!

I quote from the article below: “So Pfizer and the feds cut a deal. Instead
of charging Pfizer with a crime, prosecutors would charge a Pfizer subsidiary,
Pharmacia & Upjohn Co. Inc.

“The CNN Special Investigation found that the subsidiary is nothing more than
a shell company whose only function is to plead guilty.”

As it turned out ONE HALF of their $1.7 Billion in profits on Bextra came
from off label prescribing and the government fine for that will be
the biggest ever once again. This time the figure is $1.2 Billion plus an
additional $1 Billion to settle a batch of civil suits (how many deaths those
involved is not mentioned) and denied wrongdoing in another dozen
similar charges involving illegal promotions!

“It paid nearly $1.2 billion in a criminal fine for Bextra, the largest fine
the federal government has ever collected.

“It paid a billion dollars more to settle a batch of civil suits — although
it denied wrongdoing — on allegations that it illegally promoted 12 other
drugs.”

This begins to make one wonder just how far we will get with changes in
government policy when they have learned how to extract such large sums of money
from these drug companies in the way of fines. Why are those fines not
distributed to those who were damaged by the off label prescribing?

Ann Blake-Tracy, Executive Director
International Coalition for Drug Awareness
Author: Prozac: Panacea or Pandora? – Our Serotonin
Nightmare & Help! I Can’t Get Off My
Antidepresant!

http://articles.sfgate.com/2004-05-14/business/17426572_1_neurontin-pfizer-fda

Huge penalty in drug fraud / Pfizer settles felony case in Neurontin
off-label promotion

May
14, 2004
|By Bernadette Tansey,
Chronicle Staff Writer

A division of Pfizer Inc., the world’s largest drugmaker, has agreed to plead
guilty to two felonies and pay $430 million in penalties to settle charges that
it fraudulently promoted the drug Neurontin for a string of unapproved uses.

In an agreement announced by government prosecutors Thursday, Pfizer unit
Warner-Lambert admitted that it aggressively marketed the epilepsy drug by

illicit means for unrelated conditions including bipolar disorder, pain,
migraine headaches, and drug and alcohol withdrawal.

A company whistle-blower, whose 1996 civil suit spurred
government investigations of Neurontin’s marketing campaign, will receive about
$26.6 million through the settlement under legal provisions that reward citizens
for helping to recover government money obtained by fraud.

The settlement includes $152 million to pay back amounts spent on Neurontin
by the federal Medicare program and 50 state Medicaid programs for the poor. In
addition, Pfizer will pay a $240 million criminal fine, the second-largest such

fine ever imposed in a health care fraud prosecution, the Department of Justice
said.

Prosecutors said Warner-Lambert turned Neurontin into a blockbuster drug with
tactics like paying doctors to listen to pitches for unapproved uses and
treating them to luxury trips to Hawaii, Florida or the 1996 Olympics in
Atlanta. One doctor received almost $308,000 to tout Neurontin at conferences.

“This illegal and fraudulent promotion scheme corrupted the information
process relied on by doctors in their medical decision making, thereby putting
patients at risk,” said U.S. Attorney Michael Sullivan, chief prosecutor for the
federal district based in Boston.

Doctors are free to prescribe drugs for uses not specified on their FDA-
approved labels, but the FDA forbids drug companies from promoting them for
those off-label uses. Prosecutors said Neurontin’s manufacturers decided not to
seek an expanded FDA label for the drug, an expensive process requiring solid
proof from clinical trials. Instead, the company boosted sales through
aggressive promotional strategies, even when scientific studies had demonstrated
that it was not effective, the Justice Department said.

The tactics included planting company operatives in the audience at medical
education events to contradict unfavorable comments about Neurontin, and paying
doctors to allow sales representatives to sit in on patient visits, prosecutors
said.

Feds found Pfizer too big to nail

Submitted by Drew Kaplan on April 22, 2010 – 11:39 amOne Comment

Imagine being charged with a crime, but an imaginary friend takes the rap for
you. That is essentially what happened when Pfizer, the world’s largest
pharmaceutical company, was caught illegally marketing Bextra, a painkiller that
was taken off the market in 2005 because of safety concerns. When the criminal case was announced last fall, federal
officials touted their prosecution as a model for tough, effective enforcement.
“It sends a clear message” to the pharmaceutical industry, said Kevin Perkins,
assistant director of the FBI’s Criminal Investigative Division.

But beyond the fanfare, a CNN Special Investigation found another story, one
that officials downplayed when they declared victory. It’s a story about the
power major pharmaceutical companies have even when they break the laws intended
to protect patients.

Big plans for Bextra

The story begins in 2001, when Bextra was about to hit the market. The drug
was part of a revolutionary class of painkillers known as Cox-2 inhibitors that
were supposed to be safer than generic drugs, but at 20 times the price of
ibuprofen.

Pfizer and its marketing partner, Pharmacia, planned to sell Bextra as a
treatment for acute pain, the kind you have after surgery.

But in November 2001, the U.S. Food and Drug Administration said Bextra was
not safe for patients at high risk of heart attacks and strokes.

The FDA approved Bextra only for arthritis and menstrual cramps. It rejected
the drug in higher doses for acute, surgical pain.

Promoting drugs for unapproved uses can put patients at risk by circumventing
the FDA’s judgment over which products are safe and effective. For that reason,
“off-label” promotion is against the law.

If we prosecute Pfizer … a lot of the people who work for the company who
haven’t engaged in criminal activity would get hurt.

–Mike Loucks, federal prosecutor But with billions of dollars of profits at
stake, marketing and sales managers across the country nonetheless targeted
anesthesiologists, foot surgeons, orthopedic surgeons and oral surgeons. “Anyone
that use[d] a scalpel for a living,” one district manager advised in a document
prosecutors would later cite.

A manager in Florida e-mailed his sales reps a scripted sales pitch that
claimed — falsely — that the FDA had given Bextra “a clean bill of health” all
the way up to a 40 mg dose, which is twice what the FDA actually said was
safe.

Doctors as pitchmen

Internal company documents show that Pfizer and Pharmacia (which Pfizer later
bought) used a multimillion-dollar medical education budget to pay hundreds of
doctors as speakers and consultants to tout Bextra.

Pfizer said in court that “the company’s intent was pure”: to foster a legal
exchange of scientific information among doctors.

But an internal marketing plan called for training physicians “to serve as
public relations spokespeople.”

According to Lewis Morris, chief counsel to the inspector general at the U.S.
Department of Health and Human Services, “They pushed the envelope so far past
any reasonable interpretation of the law that it’s simply outrageous.”

Pfizer’s chief compliance officer, Doug Lanker, said that “in a large sales
force, successful sales techniques spread quickly,” but that top Pfizer
executives were not aware of the “significant mis-promotion issue with Bextra”
until federal prosecutors began to show them the evidence.

By April 2005, when Bextra was taken off the market, more than half of its

$1.7 billion in profits had come from prescriptions written for uses the FDA had
rejected.

Too big to nail

But when it came to prosecuting Pfizer for its fraudulent marketing, the
pharmaceutical giant had a trump card: Just as the giant banks on Wall Street
were deemed too big to fail, Pfizer was considered too big to nail.

Why? Because any company convicted of a major health care fraud is
automatically excluded from Medicare and Medicaid. Convicting Pfizer on Bextra
would prevent the company from billing federal health programs for any of its
products. It would be a corporate death sentence.

Prosecutors said that excluding Pfizer would most likely lead to Pfizer’s
collapse, with collateral consequences: disrupting the flow of Pfizer products
to Medicare and Medicaid recipients, causing the loss of jobs including those of
Pfizer employees who were not involved in the fraud, and causing significant
losses for Pfizer shareholders.

“We have to ask whether by excluding the company [from Medicare and
Medicaid], are we harming our patients,” said Lewis Morris of the Department of
Health and Human Services.

So Pfizer and the feds cut a deal. Instead of charging Pfizer with a crime,
prosecutors would charge a Pfizer subsidiary, Pharmacia & Upjohn Co.
Inc.

The CNN Special Investigation found that the subsidiary is nothing more than
a shell company whose only function is to plead guilty.

According to court documents, Pfizer Inc. owns (a) Pharmacia Corp., which
owns (b) Pharmacia & Upjohn LLC, which owns (c) Pharmacia & Upjohn Co.
LLC, which in turn owns (d) Pharmacia & Upjohn Co. Inc. It is the
great-great-grandson of the parent company.

Public records show that the subsidiary was incorporated in Delaware on March
27, 2007, the same day Pfizer lawyers and federal prosecutors agreed that the
company would plead guilty in a kickback case against a company Pfizer had
acquired a few years earlier.

As a result, Pharmacia & Upjohn Co. Inc., the subsidiary, was excluded
from Medicare without ever having sold so much as a single pill. And Pfizer was
free to sell its products to federally funded health programs.

An imaginary friend

I can tell you, unequivocally, that Pfizer perceived the Bextra matter as an
incredibly serious one.

Two years later, with Bextra, the shell company once again pleaded guilty. It
was, in effect, Pfizer’s imaginary friend stepping up to take the rap.

“It is true that if a company is created to take a criminal plea, but it’s
just a shell, the impact of an exclusion is minimal or nonexistent,” Morris
said.

Prosecutors say there was no viable alternative.

“If we prosecute Pfizer, they get excluded,” said Mike Loucks, the federal
prosecutor who oversaw the investigation. “A lot of the people who work for the
company who haven’t engaged in criminal activity would get hurt.”

Did the punishment fit the crime? Pfizer says yes.

It paid nearly $1.2 billion in a criminal fine for Bextra, the largest fine

the federal government has ever collected.

It paid a billion dollars more to settle a batch of civil suits — although it
denied wrongdoing — on allegations that it illegally promoted 12 other
drugs.

In all, Pfizer lost the equivalent of three months’ profit.

It maintained its ability to do business with the federal government.

Pfizer says it takes responsibility for the illegal promotion of Bextra. “I
can tell you, unequivocally, that Pfizer perceived the Bextra matter as an
incredibly serious one,” said Doug Lankler, Pfizer’s chief compliance
officer.

To prevent it from happening again, Pfizer has set up what it calls
“leading-edge” systems to spot signs of illegal promotion by closely monitoring
sales reps and tracking prescription sales.

It’s not entirely voluntary. Pfizer had to sign a corporate integrity
agreement with the Department of Health and Human Services. For the next five
years, it requires Pfizer to disclose future payments to doctors and top
executives to sign off personally that the company is obeying the law.

Pfizer says the company has learned its lesson.

But after years of overseeing similar cases against other major drug
companies, even Loucks, isn’t sure $2 billion in penalties is a deterrent when
the profits from illegal promotion can be so large.

“I worry that the money is so great,” he said, that dealing with the
Department of Justice may be “just of a cost of doing business.”

http://www.cnn.com/2010/HEALTH/04/02/pfizer.bextra/index.html?hpt=T2

1,334 total views, no views today

ANTIDEPRESSANT WITHDRAWAL: Fleeing from Arraignment: Utah

Paragraphs three & four read:  “Her attorney, Douglas
Baxter, told the judge her client had a
bad reaction
when she stopped taking an antidepressant.  ‘She had a panic attack and
took off,’  he said.”

“Bell did not even tell her family
where she was going. Her husband reported her missing and law enforcement
tracked her down at a casino on the Las Vegas strip. She was extradited back to

Utah County this week.”

http://www.deseretnews.com/article/705350662/April-trial-set-for-former-Mapleton-official-Jeannie-Bell.html

April trial set for former Mapleton official Jeannie Bell

Published: Thursday, Dec. 10, 2009 2:39 p.m. MST
PROVO ­ The
former finance controller of Mapleton accused of embezzling almost $50,000 from
the city has been ordered held on $25,000 cash-only bail.

Fourth District
Judge James Taylor set the bail Thursday and scheduled an April trial for
Jeannie Bell, 48, who skipped her arraignment on the second-degree felony theft
charge last month and fled to Las Vegas.

Her attorney, Douglas Baxter,
told the judge her client had a bad reaction when she stopped taking an

antidepressant. “She had a panic attack and took off,” he said.

Bell did
not even tell her family where she was going. Her husband reported her missing
and law enforcement tracked her down at a casino on the Las Vegas strip. She was
extradited back to Utah County this week.

Prosecutors say Bell used a
city credit card to purchase stamps and gift cards for employee bonuses, then
sold them on eBay.

­ Paul Koepp

1,874 total views, no views today

ZOLOFT: NY Judge to Allow Zoloft Defense in Assault Case

Paragraphs two and three read: “The attorney for Coram resident Brandon Hampson says he plans to argue that his client became violent and beat Lisa Essling on Aug. 25, 2006, because he stopped taking the popular antidepressant Zoloft days before the attack.”

“Nassau County District Court Judge Rhonda Fischer said Friday that she will allow a defense witness to testify that withdrawl from the antidepressant can cause a person to become aggressive.”

http://www.newsday.com/ny-judge-to-allow-zoloft-defense-in-assault-case-1.1388026

NY judge to allow “Zoloft defense” in assault case

August 22, 2009 By The Associated Press

HEMPSTEAD, N.Y. (AP) A Long Island judge has said she will allow a man accused of punching and kicking his former girlfriend to use the so-called “Zoloft defense.”

The attorney for Coram resident Brandon Hampson says he plans to argue that his client became violent and beat Lisa Essling on Aug. 25, 2006, because he stopped taking the popular antidepressant Zoloft days before the attack.

Nassau County District Court Judge Rhonda Fischer said Friday that she will allow a defense witness to testify that withdrawl from the antidepressant can cause a person to become aggressive.

Prosecutors say they strongly disagree with the court’s decision.

Zoloft manufacturer Pfizer Inc. has said there’s not evidence to suggest that discontinuing the drug can cause violent behavior.

___

Information from: Newsday, http://www.newsday.com

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

1,093 total views, no views today

ANTIDEPRESSANTS: Police Stop Man From Committing Suicide: England

Paragraphs two and three read: “The attorney for Coram resident Brandon Hampson says he plans to argue that his client became violent and beat Lisa Essling on Aug. 25, 2006, because he stopped taking the popular antidepressant Zoloft days before the attack.”

“Nassau County District Court Judge Rhonda Fischer said Friday that she will allow a defense witness to testify that withdrawl from the antidepressant can cause a person to become aggressive.”

http://www.newsday.com/ny-judge-to-allow-zoloft-defense-in-assault-case-1.1388026

NY judge to allow “Zoloft defense” in assault case

August 22, 2009 By The Associated Press

HEMPSTEAD, N.Y. (AP) A Long Island judge has said she will allow a man accused of punching and kicking his former girlfriend to use the so-called “Zoloft defense.”

The attorney for Coram resident Brandon Hampson says he plans to argue that his client became violent and beat Lisa Essling on Aug. 25, 2006, because he stopped taking the popular antidepressant Zoloft days before the attack.

Nassau County District Court Judge Rhonda Fischer said Friday that she will allow a defense witness to testify that withdrawl from the antidepressant can cause a person to become aggressive.

Prosecutors say they strongly disagree with the court’s decision.

Zoloft manufacturer Pfizer Inc. has said there’s not evidence to suggest that discontinuing the drug can cause violent behavior.

___

Information from: Newsday, http://www.newsday.com

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

1,545 total views, no views today